Peter Ganly
Impact in
- Genetics top 1%
- Chronic Lymphocytic Leukemia Research
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Hematology top 1%
- Acute Myeloid Leukemia Research
- Chronic Myeloid Leukemia Treatments
Papers in
- Hematology 25
- Multiple Myeloma Research and Treatments 10
- Acute Myeloid Leukemia Research 10
- Chronic Myeloid Leukemia Treatments 7
- Genetics 22
- Myeloproliferative Neoplasms: Diagnosis and Treatment 12
- Chronic Lymphocytic Leukemia Research 9
- Co-authors
- R.M. Rudd (2 shared papers)P S Hasleton (2 shared papers)V. Sundaresan (2 shared papers)P.H. Rabbitts (1 shared paper)N. M. Bleehen (1 shared paper)G Sinha (1 shared paper)Pamela Rabbitts (11 shared papers)Christine M. Morris (4 shared papers)
- Journals
- Blood (8 papers)Journal of Clinical Oncology (8 papers)Nucleic Acids Research (8 papers)British Journal of Haematology (6 papers)Current Medical Research and Opinion (1 paper)
- Partner nations
- New ZealandUnited KingdomUnited States
In The Last Decade
Peter Ganly
57 papers receiving 1.9k citations
Peers
Comparison fields: 5 of 93
- Genetics 798
- Hematology 767
- Pathology and Forensic Medicine 386
- Emergency Medical Services 112
- Immunology 255
Countries citing papers authored by Peter Ganly
This map shows the geographic impact of Peter Ganly's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Ganly with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Ganly more than expected).
Fields of papers citing papers by Peter Ganly
This network shows the impact of papers produced by Peter Ganly. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Ganly. The network helps show where Peter Ganly may publish in the future.
Co-authors
The 25 scholars most cited alongside Peter Ganly, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 58 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 369 | |
| 2 | 1993 | 229 | |
| 3 | 2017 | 228 | |
| 4 | 2017 | 172 | |
| 5 | 2001 | 100 | |
| 6 | 2008 | 95 | |
| 7 | 2003 | 61 | |
| 8 | 2008 | 54 | |
| 9 | 1994 | 53 | |
| 10 | 1990 | 49 | |
| 11 | 2005 | 47 | |
| 12 | 2002 | 46 | |
| 13 | 2016 | 46 | |
| 14 | 1992 | 36 | |
| 15 | 2010 | 34 | |
| 16 | 2002 | 33 | |
| 17 | 2015 | 27 | |
| 18 | Successful treatment of transplant-associated microangiopathy with rituximab. | 2009 | 22 |
| 19 | 2009 | 21 | |
| 20 | 1988 | 20 |
About Peter Ganly
Peter Ganly is a scholar working on Hematology, Genetics, Molecular Biology, Pulmonary and Respiratory Medicine and Oncology, having authored 58 papers that have together received 2.0k indexed citations. Recurring topics across this work include Myeloproliferative Neoplasms: Diagnosis and Treatment (12 papers), Multiple Myeloma Research and Treatments (10 papers), Acute Myeloid Leukemia Research (10 papers), Chronic Lymphocytic Leukemia Research (9 papers), Chronic Myeloid Leukemia Treatments (7 papers), Lymphoma Diagnosis and Treatment (5 papers), Acute Lymphoblastic Leukemia research (4 papers) and Complement system in diseases (3 papers). The work is most often cited by research in Genetics (798 citations), Hematology (767 citations), Pathology and Forensic Medicine (386 citations), Emergency Medical Services (112 citations) and Immunology (255 citations). Peter Ganly has collaborated with scholars based in New Zealand, United Kingdom and United States. Frequent co-authors include R.M. Rudd, P S Hasleton, V. Sundaresan, P.H. Rabbitts, N. M. Bleehen, G Sinha, Pamela Rabbitts, Christine M. Morris, Logan C. Walker and Caroline Dartigeas. Their work appears in journals such as Blood, Journal of Clinical Oncology, Nucleic Acids Research, British Journal of Haematology and Current Medical Research and Opinion.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.